文献速递临床试验与 GCP真实世界研究与卫生经济医学教育与科研方法

良好的临床试验资助实践:公共资助者如何降低试验失败风险并提升健康影响

Good clinical trial funding practices: how can public funders reduce the risk of trial failure and improve health impact?
PubMed 文献 · Trials · 2026-02-04

本文旨在列出欧洲公共临床试验资助者可用的良好实践,聚焦于探索产业界未研究问题的实践导向试验。研究列举了比利时KCE Trials的资助实践,以及英格兰国家健康与照护研究所(NIHR)和荷兰ZonMw的良好实践,并检索了关于公共试验资助者实践的文献。结果显示,评估单项临床试验资助实践效果的研究领域尚不充分,许多资助实践已在NIHR HTA项目中整合数十年,产生了显著的卫生影响;公共资助者实践可归纳为十大类别,包括资助者融入研究用户景观、资助团队与公共资金使用透明度、对申办方团队的支持、资助条款与数据共享、高效务实的试验设计、试验选择与改进、预算与支付、可行性与中心付款、招募与保留、结果传播与实施、资助者合作与欧盟跨国临床试验等。结论指出,实践导向临床试验的公共资助者拥有改善其资助试验健康影响的工具,但每种实践在资助项目中的相对贡献与其成本的关系仍有待研究,非商业试验的招募以及跨国非商业试验的高效资助与管理仍面临挑战。

要点

  • 公共资助者可通过十大类实践降低试验失败风险并提升健康影响。
  • NIHR HTA项目已整合多种资助实践数十年,产生显著卫生影响。
  • 商业领域部分做法已被公共资助者采用,如现场可行性核查和基于招募的付款。

核心结论

  • 实践导向临床试验的公共资助者拥有改善其资助试验健康影响的工具。
  • 每种实践在资助项目中的相对贡献与其成本的关系仍有待研究。
  • 非商业试验的招募以及跨国非商业试验的高效资助与管理仍面临挑战。

研究设计与样本

  • 本文列举了比利时公共试验资助者KCE Trials的资助实践,以及英格兰国家健康与照护研究所(NIHR)和荷兰ZonMw的良好实践。
  • 检索了关于公共试验资助者实践的文献。
  • 聚焦于探索产业界未研究问题的实践导向试验。

主要发现

  • 评估单项临床试验资助实践效果的研究领域尚不充分。
  • 许多资助实践已在NIHR HTA项目中整合数十年,产生了具有显著卫生影响的试验。
  • 商业领域部分做法现已被公共试验资助者采用,如针对招募能力的现场可行性核查以及基于参与者招募和保留向中心付款。
  • 公共资助者实践可归纳为十大类别:资助者融入研究用户景观;资助者团队与公共资金使用透明度;对申办方团队的支持;资助条款、访问权与数据共享;高效务实的试验设计;试验选择与改进;预算与支付、可行性核查和中心付款的重要性;招募与保留;结果传播与实施;资助者合作与欧盟跨国临床试验。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 评估单项临床试验资助实践效果的研究领域尚不充分。
  • 每种实践在资助项目中的相对贡献与其成本的关系仍有待研究。
  • 非商业试验的招募以及跨国非商业试验的高效资助与管理仍面临挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinical trial funders aim for trials conducted with high quality, within the planned time and budget. The majority of non-commercial investigator-initiated clinical trials do not complete participant recruitment in time or are discontinued early. In addition, the implementation of the results may be challenging. We aim to list the good practices available for public funders of clinical trials in Europe. Our focus is on practice-oriented trials exploring research questions not studied by industry. METHODS: We list the funding practices at the public trial funder KCE Trials in Belgium, together with good practices identified at the National Institute of Health and Care Research (NIHR) in England and ZonMw in The Netherlands. The literature on practices of public trial funders was searched. RESULTS: Assessment of the effectiveness of individual clinical trial funding practices is an under-studied area of research. Many funding practices have been integrated for decades in the NIHR HTA program, resulting in trials with significant health impact. Some practices of the commercial sector are now also used by public trial funders, such as on-site feasibility checks for recruitment capacity and paying sites based on participant recruitment and retention. The array of public funder practices with the collective aim to reduce risk and enhance impact can be grouped into ten categories: integration of the funder in the research user landscape; the funder's team and transparency in the use of public money; support for the sponsor's team; the terms and conditions of the funding, access rights and data sharing; an efficient and pragmatic trial design; trial selection and improvement; budget and payments, the importance of feasibility checks and site payments; recruitment and retention; dissemination and implementation of results; collaboration between funders and multi-national clinical trials in the EU. CONCLUSIONS: Public funders of practice-oriented clinical trials have tools available to improve the health impact of the trials they fund. The relative contribution of each practice in a funding program in relation to its cost remains to be studied. Challenges remain for recruitment in non-commercial trials and efficient funding and management of multi-national non-commercial trials.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Hulstaert F, Harrison J, Nevens H, et al. Good clinical trial funding practices: how can public funders reduce the risk of trial failure and improve health impact? Trials. 2026. PMID: 41634783. doi:10.1186/s13063-026-09511-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。